• Klíčová slova
• EZ karta, e žádanka,
• MeSH
• chorobopisy - počítačové systémy zákonodárství a právo   MeSH
• digitální technologie MeSH
• elektronické zdravotní záznamy zákonodárství a právo   MeSH
• Evropská unie organizace a řízení   MeSH
• lidé MeSH
• poskytování zdravotní péče * zákonodárství a právo   MeSH
• telemedicína zákonodárství a právo   MeSH
• zabezpečení počítačových systémů zákonodárství a právo   MeSH
• Check Tag
• lidé MeSH

• MeSH
• Evropská unie MeSH
• incidence MeSH
• kardiovaskulární nemoci * epidemiologie   mortalita   MeSH
• lidé MeSH
• prevalence MeSH
• rizikové faktory kardiovaskulárních chorob MeSH
• Check Tag
• lidé MeSH
• Publikační typ
• přehledy MeSH
• Geografické názvy
• Česká republika MeSH

• MeSH
• digitální zdraví * MeSH
• elektronické zdravotní záznamy MeSH
• Evropská unie MeSH
• lidé MeSH
• telemedicína zákonodárství a právo   MeSH
• zdravotní gramotnost MeSH
• zdravotnické informační systémy MeSH
• Check Tag
• lidé MeSH
• Publikační typ
• přehledy MeSH
• Geografické názvy
• Česká republika MeSH

• MeSH
• Evropská unie MeSH
• jazyk (prostředek komunikace) * MeSH
• kardiopulmonální resuscitace metody   MeSH
• lidé MeSH
• Check Tag
• lidé MeSH
• Publikační typ
• dopisy MeSH

BACKGROUND: Somatic and germline genetic alterations are significant drivers of cancer. Increasing integration of new technologies which profile these alterations requires timely, equitable and high-quality genetic counselling to facilitate accurate diagnoses and informed decision-making by patients and their families in preventive and clinical settings. This article aims to provide an overview of genetic counselling legislation and practice across European Union (EU) Member States to serve as a foundation for future European recommendations and action. METHODS: National legislative databases of all 27 Member States were searched using terms relevant to genetic counselling, translated as appropriate. Interviews with relevant experts from each Member State were conducted to validate legislative search results and provide detailed insights into genetic counselling practice in each country. RESULTS: Genetic counselling is included in national legislative documents of 22 of 27 Member States, with substantial variation in legal mechanisms and prescribed details (i.e. the 'who, what, when and where' of counselling). Practice is similarly varied. Workforce capacity (25 of 27 Member States) and genetic literacy (all Member States) were common reported barriers. Recognition and/or better integration of genetic counsellors and updated legislation and were most commonly noted as the 'most important change' which would improve practice. CONCLUSIONS: This review highlights substantial variability in genetic counselling across EU Member States, as well as common barriers notwithstanding this variation. Future recommendations and action should focus on addressing literacy and capacity challenges through legislative, regulatory and/or strategic approaches at EU, national, regional and/or local levels.

• MeSH
• Evropská unie * MeSH
• genetické poradenství * zákonodárství a právo   MeSH
• genetické testování zákonodárství a právo   MeSH
• lidé MeSH
• nádory * genetika   MeSH
• Check Tag
• lidé MeSH
• Publikační typ
• časopisecké články MeSH

Given the enormous scale of the COVID-19 pandemic affecting the healthcare sector, limited human resource capacity, and efforts to prevent the spread of COVID-19, occupational health protection could not escape changes. The aim was to identify and compare the regulations regarding the provision of medical occupational check-ups (MOCs) during the pandemic in all European Union member states (EU MS). The study employed the Delphi method, involving experts from EU MS to assess MOC regulations between January 2020 and May 2021. Experts were queried regarding the existence and specifics of MOC regulations, particularly for entrance and periodic MOCs at hazardous and non-hazardous workplaces. Out of the 27 EU MS surveyed, 13 EU MS did not regulate MOCs, while 14 EU MS (51.6%) regulated the provision of MOCs. The regulations were changes in the way MOCs were provided, modifications (postponement in time, alternative provision, e.g. using telemedicine or online connection, or replacing the medical certificate of fitness to work based on the MOC with a declaration by the worker), or interruption without compensation, even for hazardous works. The regulations were in effect for different lengths of time and varied in some countries during the study period. The cumulative duration of MOC interruptions in all EU MS during the study period was 137 months (7.5% of the cumulative study period of 1836 months). Given the different approaches to the provision of MOCs in EU MS, it has proved appropriate to develop an optimal unified framework plan for future similar situations.

• MeSH
• COVID-19 * prevence a kontrola   epidemiologie   MeSH
• delfská metoda MeSH
• Evropská unie * MeSH
• fyzikální vyšetření MeSH
• hygiena práce * MeSH
• lidé MeSH
• pandemie prevence a kontrola   MeSH
• SARS-CoV-2 * MeSH
• služby zdravotní péče o pracující MeSH
• Check Tag
• lidé MeSH
• Publikační typ
• časopisecké články MeSH

According to the European Union (EU) Directive 2005/36, the medical specialty of oral and maxillofacial surgery (OMFS) exists with two possible formats: dual degree OMFS called Dental, Oral and Maxillofacial Surgery (DOMFS) - basic medical and basic dental training and single medical degree Maxillofacial Surgery (MFS). Within the EU and across all of Europe, differences in the nature and quality of OMFS training coexist. By implementing the highest possible standards of training, patient care can be improved. To establish quality metrics for an ideal OMFS training programme, the European OMFS Trainee Forum of the Union Européenne des Médecins Spécialistes (UEMS) conducted a Delphi consensus protocol from November 2023 to January 2024. Facilitated by the OMFS Section of UEMS, 57 trainees from 32 countries participated. The process involved the definition of three quality levels using the red, amber, and green (RAG) rating system. Following the Delphi process, 46 domains were identified, including features within training programmes/rotations, teaching and education programmes, training placements, recording of training progression and activity, and external assessment of training programmes. The results were aligned with the UEMS OMFS European Training Requirement (ETR). With the introduction of a RAG rating, trainees and trainers can review their training programmes with the aim of improving them by moving domains from Red to Green. Raising the standard of training will benefit our patients. This initiative could mark a significant step towards the harmonisation of OMFS training, improving quality and ensuring consistent, high-level care throughout Europe.

• MeSH
• delfská metoda * MeSH
• Evropská unie MeSH
• klinické kompetence normy   MeSH
• lidé MeSH
• stomatochirurgie * výchova   normy   MeSH
• studium stomatologie specializační postgraduální normy   MeSH
• Check Tag
• lidé MeSH
• Publikační typ
• časopisecké články MeSH
• přehledy MeSH
• Geografické názvy
• Evropa MeSH

• Klíčová slova
• Evropská federace sester, společné prohlášení,
• MeSH
• antibiotická rezistence MeSH
• Evropská unie MeSH
• společnosti ošetřovatelské MeSH
• zdravotní sestry MeSH
• Publikační typ
• novinové články MeSH

BACKGROUND: In the two European Union (EU)-funded projects, PCM4EU (Personalized Cancer Medicine for all EU citizens) and PRIME-ROSE (Precision Cancer Medicine Repurposing System Using Pragmatic Clinical Trials), we aim to facilitate implementation of precision cancer medicine (PCM) in Europe by leveraging the experience from ongoing national initiatives that have already been particularly successful. PATIENTS AND METHODS: PCM4EU and PRIME-ROSE gather 17 and 24 partners, respectively, from 19 European countries. The projects are based on a network of Drug Rediscovery Protocol (DRUP)-like clinical trials that are currently ongoing or soon to start in 11 different countries, and with more trials expected to be established soon. The main aims of both the projects are to improve implementation pathways from molecular diagnostics to treatment, and reimbursement of diagnostics and tumour-tailored therapies to provide examples of best practices for PCM in Europe. RESULTS: PCM4EU and PRIME-ROSE were launched in January and July 2023, respectively. Educational materials, including a podcast series, are already available from the PCM4EU website (http://www.pcm4eu.eu). The first reports, including an overview of requirements for the reimbursement systems in participating countries and a guide on patient involvement, are expected to be published in 2024. CONCLUSION: PCM4EU and PRIME-ROSE were launched in January and July 2023, respectively. Educational materials, including a podcast series, are already available from the PCM4EU website (http://www.pcm4eu.eu). The first reports, including an overview of requirements for the reimbursement systems in participating countries and a guide on patient involvement, are expected to be published in 2024. CONCLUSION: European collaboration can facilitate the implementation of PCM and thereby provide affordable and equitable access to precision diagnostics and matched therapies for more patients.

• MeSH
• Evropská unie MeSH
• individualizovaná medicína * metody   MeSH
• klinické zkoušky jako téma organizace a řízení   MeSH
• lidé MeSH
• nádory * terapie   MeSH
• přehodnocení terapeutických indikací léčivého přípravku MeSH
• Check Tag
• lidé MeSH
• Publikační typ
• časopisecké články MeSH
• Geografické názvy
• Evropa MeSH

• MeSH
• chorobopisy zákonodárství a právo   MeSH
• Evropská unie MeSH
• lidé MeSH
• ochrana zájmů pacientů zákonodárství a právo   MeSH
• osobní údaje zákonodárství a právo   MeSH
• poskytování zdravotní péče zákonodárství a právo   MeSH
• přístup pacientů ke zdravotnickým záznamům * zákonodárství a právo   MeSH
• role soudu MeSH
• vztahy mezi lékařem a pacientem MeSH
• zákonodárství jako téma MeSH
• Check Tag
• lidé MeSH